BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29776607)

  • 1. Differentiation of equine bone marrow derived mesenchymal stem cells increases the expression of immunogenic genes.
    Barrachina L; Remacha AR; Romero A; Zaragoza P; Vázquez FJ; Rodellar C
    Vet Immunol Immunopathol; 2018 Jun; 200():1-6. PubMed ID: 29776607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
    Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.
    De Schauwer C; Goossens K; Piepers S; Hoogewijs MK; Govaere JL; Smits K; Meyer E; Van Soom A; Van de Walle GR
    Stem Cell Res Ther; 2014 Jan; 5(1):6. PubMed ID: 24418262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
    Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
    Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and immunogenicity of bone marrow-derived mesenchymal stem cells under osteoporotic conditions.
    Huang Y; Yin Y; Gu Y; Gu Q; Yang H; Zhou Z; Shi Q
    Sci China Life Sci; 2020 Mar; 63(3):429-442. PubMed ID: 31879847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.
    Schnabel LV; Pezzanite LM; Antczak DF; Felippe MJ; Fortier LA
    Stem Cell Res Ther; 2014 Jan; 5(1):13. PubMed ID: 24461709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
    Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
    Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells.
    Liu Y; Deng B; Zhao Y; Xie S; Nie R
    Dev Growth Differ; 2013 Jun; 55(5):591-605. PubMed ID: 23557080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.
    Branly T; Contentin R; Desancé M; Jacquel T; Bertoni L; Jacquet S; Mallein-Gerin F; Denoix JM; Audigié F; Demoor M; Galéra P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-derived mesenchymal stromal (stem) cells differentiate to osteoblast and chondroblast lineages upon incubation with conditioned media from dental pulp stem cell-derived osteoblasts and auricle cartilage chondrocytes.
    Carbone A; Valente M; Annacontini L; Castellani S; Di Gioia S; Parisi D; Rucci M; Belgiovine G; Colombo C; Di Benedetto A; Mori G; Lo Muzio L; Maiorella A; Portincasa A; Conese M
    J Biol Regul Homeost Agents; 2016; 30(1):111-22. PubMed ID: 27049081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
    Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
    Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules.
    Chen X; McClurg A; Zhou GQ; McCaigue M; Armstrong MA; Li G
    Stem Cells; 2007 Feb; 25(2):364-70. PubMed ID: 17068184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
    Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
    Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression.
    Kamm JL; Parlane NA; Riley CB; Gee EK; Dittmer KE; McIlwraith CW
    PLoS One; 2019; 14(11):e0225161. PubMed ID: 31747418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells.
    Lepage SI; Nagy K; Sung HK; Kandel RA; Nagy A; Koch TG
    Stem Cells Dev; 2016 Jan; 25(1):80-9. PubMed ID: 26414480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative characteristics of mesenchymal stem cells derived from reamer-irrigator-aspirator, iliac crest bone marrow, and adipose tissue.
    Toosi S; Naderi-Meshkin H; Kalalinia F; Peivandi MT; Hossein Khani H; Bahrami AR; Heirani-Tabasi A; Mirahmadi M; Behravan J
    Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(10):68-74. PubMed ID: 27609477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of equine, bone marrow-derived mesenchymal stem cells demonstrates differences within age- and gender-matched horses.
    Carter-Arnold JL; Neilsen NL; Amelse LL; Odoi A; Dhar MS
    Equine Vet J; 2014 Sep; 46(5):589-95. PubMed ID: 23855680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.
    Huang XP; Ludke A; Dhingra S; Guo J; Sun Z; Zhang L; Weisel RD; Li RK
    FASEB J; 2016 Sep; 30(9):3069-82. PubMed ID: 27221978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.